International Scholarly Research Notices / 2014 / Article / Tab 1

Clinical Study

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients

Table 1

Clinical and demographic data (). Values are reported as median (interquartile range) or number (%).

Age (years)62.5 (57–73)
 AA54 (69.2%)
 Caucasian24 (30.8%)
Marital Status
 Married44 (56.4%)
 SDW33 (43.6%)
BMI (kg/m2)27.5 (23.5–33.3)
CCI3 (2–4)
PSA (ng/mL)34.3 (24.2–55.4)
Prior PSA, yes53 (67.9%)
Prior biopsy, yes16 (20.5%)
Biopsy results, positive*66 (84.6%)
Gleason score ()
 65 (7.6%)
 717 (25.8%)
 8–1044 (66.7%)
Clinical stage ()
 T1c33 (50%)
 T2a8 (12.1%)
 T2b11 (16.7%)
 T2c7 (10.6%)
 T3a5 (7.6%)
 T3b2 (3%)

AA: African-American, BMI: body mass index, CCI: Charlson Comorbidity Index, PSA: prostate-specific antigen, SDW: single, divorced, or widowed.
*One patient had two prior negative biopsies; one patient had one prior negative biopsy.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.